title: Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease.
abstract: OBJECTIVE
  To determine the outcome of initial trabeculectomy with mitomycin C (MMC) in the management of secondary glaucoma associated with Behçet disease (BD) in a 1-year follow-up period.
  
  
  METHODS
  Twenty-three eyes of 13 cases with secondary glaucoma associated with BD, were evaluated prospectively. They underwent primary trabeculectomy with MMC. The operative success was defined as an intraocular pressure (IOP) < or =20 mm Hg (+/- medical therapy) in the absence of phthisis and without the necessity of further surgery for glaucoma and success rates at the postoperative first day, first month, sixth month, and first year were determined.
  
  
  RESULTS
  Success was achieved in all of the eyes (100%) at the postoperative first day and month, in 21 eyes (91.3%) at the postoperative sixth month and in 19 eyes (82.6%) at the postoperative first year. The mean preoperative IOP was 30.9+/-5.3 mm Hg under the mean 3.3+/-0.7 antiglaucoma medications but it reduced to 16.8+/-3.1 mm Hg under the mean 1.7+/-0.8 medications at the postoperative sixth month and 18.5+/-3.2 mm Hg under the mean 2.6+/-1.1 medications at the postoperative first year.
  
  
  CONCLUSIONS
  Trabeculectomy with MMC provides reduction of IOP and the number of antiglaucoma medications in cases with secondary glaucoma associated with BD in a 1-year follow-up period.
authors.affiliation: M.D. Ankara Ulucanlar Eye Research Hospital, Ankara, Turkey. ufukelgin@superonline.com
authors.forename: Ufuk
authors.initials: U
authors.lastname: Elgin
authors.forename: Nilufer
authors.initials: N
authors.lastname: Berker
authors.forename: Aygen
authors.initials: A
authors.lastname: Batman
authors.forename: Emel
authors.initials: E
authors.lastname: Soykan
mesh_terms: D000293:Adolescent; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D000959:Antihypertensive Agents / Q000008:administration & dosage; D001528:Behcet Syndrome / Q000150:complications*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D005901:Glaucoma / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery*; D006801:Humans; D007429:Intraocular Pressure; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage*; D011446:Prospective Studies; D014130:Trabeculectomy; D016896:Treatment Outcome; D014792:Visual Acuity
chemical_list: D000903:Antibiotics, Antineoplastic; D000959:Antihypertensive Agents; D016685:Mitomycin